These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 25203323)
21. GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion. Chen KY; Chen CC; Tseng YL; Chang YC; Chang MC Oncotarget; 2014 Jul; 5(13):5017-28. PubMed ID: 24970809 [TBL] [Abstract][Full Text] [Related]
22. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell. Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007 [TBL] [Abstract][Full Text] [Related]
23. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
24. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622 [TBL] [Abstract][Full Text] [Related]
25. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238 [TBL] [Abstract][Full Text] [Related]
26. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1. Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706 [TBL] [Abstract][Full Text] [Related]
27. Natural antisense transcript TPM1-AS regulates the alternative splicing of tropomyosin I through an interaction with RNA-binding motif protein 4. Huang GW; Zhang YL; Liao LD; Li EM; Xu LY Int J Biochem Cell Biol; 2017 Sep; 90():59-67. PubMed ID: 28754317 [TBL] [Abstract][Full Text] [Related]
28. Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation. Brooks YS; Wang G; Yang Z; Smith KK; Bieberich E; Ko L J Biol Chem; 2009 Jul; 284(27):18033-46. PubMed ID: 19416963 [TBL] [Abstract][Full Text] [Related]
29. RBM4 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Modulating Alternative Splicing of Pyruvate Kinase M. Su CH; Hung KY; Hung SC; Tarn WY Mol Cell Biol; 2017 Feb; 37(3):. PubMed ID: 27821480 [TBL] [Abstract][Full Text] [Related]
30. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H. Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397 [TBL] [Abstract][Full Text] [Related]
31. RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing. Lin JC; Tarn WY J Cell Biol; 2011 May; 193(3):509-20. PubMed ID: 21518792 [TBL] [Abstract][Full Text] [Related]
32. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Du L; Zhao Z; Ma X; Hsiao TH; Chen Y; Young E; Suraokar M; Wistuba I; Minna JD; Pertsemlidis A Oncogene; 2014 Aug; 33(34):4307-15. PubMed ID: 24037530 [TBL] [Abstract][Full Text] [Related]
33. NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression. Liu S; Lin C; Lin X; Lin P; He R; Pan X; Lin Y; Ye J; Zhu G Cancer Res; 2024 Oct; 84(19):3207-3222. PubMed ID: 39024555 [TBL] [Abstract][Full Text] [Related]
34. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling. Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159 [TBL] [Abstract][Full Text] [Related]
35. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling. Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408 [TBL] [Abstract][Full Text] [Related]
36. RBM4 Modulates Radial Migration via Alternative Splicing of Dab1 during Cortex Development. D D; Hung KY; Tarn WY Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581187 [TBL] [Abstract][Full Text] [Related]
38. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells. Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768 [TBL] [Abstract][Full Text] [Related]
39. The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells. Liang YC; Lin WC; Lin YJ; Lin JC Oncotarget; 2015 Nov; 6(35):38046-60. PubMed ID: 26506517 [TBL] [Abstract][Full Text] [Related]
40. Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis. Shapiro BA; Vu NT; Shultz MD; Shultz JC; Mietla JA; Gouda MM; Yacoub A; Dent P; Fisher PB; Park MA; Chalfant CE J Biol Chem; 2016 Oct; 291(41):21669-21681. PubMed ID: 27519412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]